SEO Content
Title
Home - VLVbio
Length : 13
Perfect, your title contains between 10 and 70 characters.
Description
Length : 0
Very bad. We haven't found meta description on your page. Use this free online meta tags generator to create description.
Keywords
Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.
Og Meta Properties
Good, your page take advantage of Og Properties.
| Property | Content |
|---|---|
| locale | en_US |
| type | website |
| title | Home - VLVbio |
| description | M30 Apoptosense® in NASH The M30 Apoptosense® ELISA can be used as an aid in diagnosing patients with NASH which would allow for an early identification of patients at risk of developing late stage liver disease and would benefit from specialist care. Diagnosing NASH also allows an earlier intervention prior to the onset of fibrosis […] |
| url | https://vlvbio.com/ |
| site_name | VLVbio |
| image | https://vlvbio.com/wp-content/uploads/2023/05/foto.png |
Headings
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 36 | 13 | 5 | 0 | 0 |
- [H1] CREATING A WORLD WITH NO UNDIAGNOSED LIVER DISEASES
- [H2] Thank you for being part of our 2025
- [H2] Global Fatty Liver Day
- [H2] Play For Your Liver
- [H2] The EASL Congress 2025
- [H2] M30 Apoptosense® in NASH
- [H2] NAFLD NASH ALD ASH DILI ALF ACLF NAFLD NASH ALD ASH DILI ALF ACLF NAFLD NASH ALD ASH DILI ALF ACLF NAFLD NASH ALD ASH DILI ALF ACLF NAFLD NASH ALD ASH DILI ALF ACLF
- [H2] NAFLD – a global disease
- [H2] NASH
- [H2] Long Experience
- [H2] Cost-effective and easy to use
- [H2] Clinical Validation
- [H2] Clinical pharmacology trials
- [H2] Research Collaborations
- [H2] Continuous Innovation
- [H2] Our Insights
- [H2] Who Is at Risk?
- [H2] The Importance of Tailored Diagnostics
- [H2] Targeted Interventions for High-Risk Groups
- [H2] Preventing the Burden of Advanced Liver Disease
- [H2] Conclusion
- [H2] The Role of Lifestyle Changes in MASLD Management
- [H2] The Importance of Monitoring Tools
- [H2] Integrating Monitoring into MASLD Care
- [H2] A Balanced Approach to MASLD Monitoring
- [H2] A Collaborative Approach to MASLD Care
- [H2] Conclusion
- [H2] Why Early Diagnosis Matters
- [H2] Overview of Non-Invasive Testing Options
- [H2] How Non-Invasive Tests Improve Patient Outcomes
- [H2] Cost-Effectiveness of Early Diagnosis
- [H2] Conclusion
- [H2] What is MASLD?
- [H2] The Growing Global Prevalence of MASLD
- [H2] Why Early Diagnosis is Critical
- [H2] Conclusion
- [H2] Do you have any questions or want to learn more about the field?
- [H3] The right to good health is a fundamental human right. Therefore we strive to offer and facilitate high-quality biomarker assays to detect and measure liver disease in an effective, sensitive and cost-effective way.
- [H3] K18 – the Key to Unlocking Informed Decisions in MASH Drug Trials
- [H3] Launch of IMMUNIS Cytokeratin 18F EIA by Institute of Immunology, Japan
- [H3] Thank you for being part of our 2025
- [H3] Global Fatty Liver Day
- [H3] Play For Your Liver
- [H3] The EASL Congress 2025
- [H3] High-Risk Populations and Targeted Interventions in MASLD
- [H3] Managing MASLD: Lifestyle Changes and Tools for Long-Term Liver Health
- [H3] The Importance of Non-Invasive Testing in Early MASLD Diagnosis
- [H3] Understanding MASLD and Its Growing Global Prevalence
- [H3] Keratin 18 in Alcohol-associated Liver Disease
- [H3] The EASL Congress 2024
- [H4] Silent Progression to Severe Disease
- [H4] Preventing Cirrhosis and Liver Cancer
- [H4] Role of Non-Invasive Diagnostics
- [H4] Managing High-Risk Populations
- [H4] Improving Patient Outcomes and Reducing Costs
Images
We found 31 images on this web page.
30 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.
Text/HTML Ratio
Ratio : 20%
Good, this page's ratio of text to HTML code is higher than 15, but lower than 25 percent.
Flash
Perfect, no Flash content has been detected on this page.
Iframe
Great, there are no Iframes detected on this page.
SEO Links
URL Rewrite
Good. Your links looks friendly!
Underscores in the URLs
Perfect! No underscores detected in your URLs.
In-page links
We found a total of 27 links including 1 link(s) to files
SEO Keywords
Keywords Cloud
liver health masld healthcare m30 more tools patients early disease
Keywords Consistency
| Keyword | Content | Title | Keywords | Description | Headings |
|---|---|---|---|---|---|
| liver | 111 |  |
|
|
 |
| masld | 67 | |
|
|
|
| disease | 56 | |
|
|
|
| patients | 48 | |
|
|
|
| early | 44 | |
|
|
|
Usability
Url
Domain : m30.ch
Length : 6
Favicon
Great, your website has a favicon.
Printability
We could not find a Print-Friendly CSS.
Language
Good. Your declared language is en.
Dublin Core
This page does not take advantage of Dublin Core.
Document
Doctype
HTML 5
Encoding
Perfect. Your declared charset is UTF-8.
W3C Validity
Errors : 0
Warnings : 0
Email Privacy
Warning! At least one email address has been found in the plain text. Use free antispam protector to hide email from spammers.
Deprecated HTML
Great! We haven't found deprecated HTML tags in your HTML.
Speed Tips
|
Excellent, your website doesn't use nested tables. |
|
Too bad, your website is using inline styles. |
|
Great, your website has few CSS files. |
|
Too bad, your website has too many JS files (more than 6). |
|
Perfect, your website takes advantage of gzip. |
Mobile
Mobile Optimization
|
Apple Icon |
|
Meta Viewport Tag |
|
Flash content |
Optimization
XML Sitemap
Great, your website has an XML sitemap.
| https://vlvbio.com/sitemap_index.xml |
Robots.txt
http://m30.ch/robots.txt
Great, your website has a robots.txt file.
Analytics
Missing
We didn't detect an analytics tool installed on this website.
Web analytics let you measure visitor activity on your website. You should have at least one analytics tool installed, but It can also be good to install a second in order to cross-check the data.
PageSpeed Insights
Device
Categories
Website-SEO-Überprüfung
Website-SEO-Überprüfung is a free SEO tool which provides you content analysis of the website.